Two Mega-Mergers Were Just The Highlights Of A Year Of Major Deals

 
• By Joseph Haas
  
Scrip Perspectives 2019 to 2020
2019 saw two biopharma mega-mergers and 23 deals with upfront value of $1bn or more

More from Deals

More from Business